$195.14
0.15%
Downside
Day's Volatility :2.27%
Upside
2.12%
5.83%
Downside
52 Weeks Volatility :25.41%
Upside
20.79%
Period | Idex Corporation | Sector (Industrials) | S&P500 |
---|---|---|---|
3 Months | -3.3% | 2.9% | 1.1% |
6 Months | -18.26% | 2.7% | 4.9% |
1 Year | -10.69% | 18.6% | 21.5% |
3 Years | -10.14% | 22.5% | 19.7% |
Market Capitalization | 14.9B |
Book Value | $48.14 |
Dividend Share | 2.66 |
Dividend Yield | 1.41% |
Earnings Per Share (EPS) | 7.65 |
PE Ratio | 25.51 |
PEG Ratio | 2.17 |
Wall Street Target Price | 225.42 |
Profit Margin | 18.19% |
Operating Margin TTM | 23.11% |
Return On Assets TTM | 7.6% |
Return On Equity TTM | 16.73% |
Revenue TTM | 3.2B |
Revenue Per Share TTM | 42.17 |
Quarterly Revenue Growth YOY | -4.6% |
Gross Profit TTM | 1.4B |
EBITDA | 865.4M |
Diluted Eps TTM | 7.65 |
Quarterly Earnings Growth YOY | 0.02 |
EPS Estimate Current Year | 7.86 |
EPS Estimate Next Year | 8.53 |
EPS Estimate Current Quarter | 2.04 |
EPS Estimate Next Quarter | 2.19 |
What analysts predicted
Upside of 15.52%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 2.5B | ↑ 8.58% |
Net Income | 410.6M | ↑ 21.74% |
Net Profit Margin | 16.53% | ↑ 1.79% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 2.5B | ↑ 0.44% |
Net Income | 425.5M | ↑ 3.64% |
Net Profit Margin | 17.06% | ↑ 0.53% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 2.4B | ↓ 5.73% |
Net Income | 377.8M | ↓ 11.21% |
Net Profit Margin | 16.07% | ↓ 0.99% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.8B | ↑ 17.57% |
Net Income | 449.4M | ↑ 18.95% |
Net Profit Margin | 16.25% | ↑ 0.18% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 3.2B | ↑ 15.09% |
Net Income | 586.9M | ↑ 30.6% |
Net Profit Margin | 18.44% | ↑ 2.19% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 3.3B | ↑ 2.89% |
Net Income | 596.1M | ↑ 1.57% |
Net Profit Margin | 18.21% | ↓ 0.23% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 845.4M | ↑ 4.28% |
Net Income | 139.8M | ↑ 7.54% |
Net Profit Margin | 16.54% | ↑ 0.5% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 846.2M | ↑ 0.09% |
Net Income | 138.6M | ↓ 0.86% |
Net Profit Margin | 16.38% | ↓ 0.16% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 793.4M | ↓ 6.24% |
Net Income | 209.1M | ↑ 50.87% |
Net Profit Margin | 26.35% | ↑ 9.97% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 788.9M | ↓ 0.57% |
Net Income | 108.6M | ↓ 48.06% |
Net Profit Margin | 13.77% | ↓ 12.58% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 800.5M | ↑ 1.47% |
Net Income | 121.4M | ↑ 11.79% |
Net Profit Margin | 15.17% | ↑ 1.4% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 807.2M | ↑ 0.84% |
Net Income | 141.3M | ↑ 16.39% |
Net Profit Margin | 17.5% | ↑ 2.33% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 3.5B | ↑ 2.09% |
Total Liabilities | 1.5B | ↓ 2.34% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 3.8B | ↑ 9.89% |
Total Liabilities | 1.6B | ↑ 4.94% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 4.4B | ↑ 15.74% |
Total Liabilities | 1.9B | ↑ 20.85% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 4.9B | ↑ 11.39% |
Total Liabilities | 2.1B | ↑ 12.81% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 5.5B | ↑ 12.09% |
Total Liabilities | 2.5B | ↑ 16.94% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 5.9B | ↑ 6.41% |
Total Liabilities | 2.3B | ↓ 6.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.7B | ↑ 2.65% |
Total Liabilities | 2.4B | ↓ 1.77% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.7B | ↑ 1.09% |
Total Liabilities | 2.4B | ↑ 0.51% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.7B | ↓ 0.88% |
Total Liabilities | 2.3B | ↓ 6.5% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.9B | ↑ 3.45% |
Total Liabilities | 2.3B | ↑ 1.82% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 5.9B | ↑ 0.41% |
Total Liabilities | 2.3B | ↓ 2.28% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 5.9B | ↑ 0.24% |
Total Liabilities | 2.2B | ↓ 0.93% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 479.3M | ↑ 10.77% |
Investing Cash Flow | -81.4M | ↑ 48.74% |
Financing Cash Flow | -290.0M | ↑ 4.54% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 528.1M | ↑ 10.16% |
Investing Cash Flow | -137.0M | ↑ 68.26% |
Financing Cash Flow | -227.6M | ↓ 21.53% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 569.3M | ↑ 7.8% |
Investing Cash Flow | -172.6M | ↑ 25.95% |
Financing Cash Flow | -42.6M | ↓ 81.28% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 565.3M | ↓ 0.7% |
Investing Cash Flow | -698.1M | ↑ 304.52% |
Financing Cash Flow | -9.5M | ↓ 77.7% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 557.4M | ↓ 1.4% |
Investing Cash Flow | -917.2M | ↑ 31.39% |
Financing Cash Flow | -38.3M | ↑ 303.16% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 147.9M | ↓ 11.6% |
Investing Cash Flow | -29.2M | ↓ 96.82% |
Financing Cash Flow | -45.2M | ↓ 119.13% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 141.2M | ↓ 4.53% |
Investing Cash Flow | -147.4M | ↑ 404.79% |
Financing Cash Flow | -46.8M | ↑ 3.54% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 226.6M | ↑ 60.48% |
Investing Cash Flow | -90.0M | ↓ 38.94% |
Financing Cash Flow | -194.7M | ↑ 316.03% |
Sell
Neutral
Buy
Idex Corporation is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
![]() Idex Corporation | 2.4% | -18.26% | -10.69% | -10.14% | 16.2% |
![]() Emerson Electric Co. | -1.36% | -10.96% | -1.22% | -5.29% | 53.95% |
![]() Illinois Tool Works Inc. | 2.85% | -6.84% | 2.18% | 9.94% | 58.48% |
![]() Parker-hannifin Corporation | 11.48% | 5.9% | 39.65% | 97.07% | 221.94% |
![]() Cummins Inc. | 0.42% | 10.14% | 26.08% | 25.38% | 82.32% |
![]() Eaton Corporation Plc | 2.63% | -5.37% | 21.36% | 74.08% | 235.85% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
![]() Idex Corporation | 25.51 | 25.51 | 2.17 | 7.86 | 0.17 | 0.08 | 0.01 | 48.14 |
![]() Emerson Electric Co. | 33.74 | 33.74 | 2.3 | 5.48 | 0.06 | 0.04 | 0.02 | 36.36 |
![]() Illinois Tool Works Inc. | 23.81 | 23.81 | 2.46 | 10.33 | 1.01 | 0.17 | 0.02 | 9.97 |
![]() Parker-hannifin Corporation | 26.32 | 26.32 | 2.69 | 24.84 | 0.25 | 0.08 | 0.01 | 93.85 |
![]() Cummins Inc. | 21.0 | 21.0 | 0.61 | 19.71 | 0.19 | 0.07 | 0.02 | 69.69 |
![]() Eaton Corporation Plc | 31.45 | 31.45 | 2.18 | 10.63 | 0.2 | 0.07 | 0.01 | 48.28 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
![]() Idex Corporation | Buy | $14.9B | 16.2% | 25.51 | 18.19% |
![]() Emerson Electric Co. | Buy | $57.2B | 53.95% | 33.74 | 10.12% |
![]() Illinois Tool Works Inc. | Hold | $72.3B | 58.48% | 23.81 | 19.15% |
![]() Parker-hannifin Corporation | Buy | $74.0B | 221.94% | 26.32 | 14.27% |
![]() Cummins Inc. | Hold | $40.7B | 82.32% | 21.0 | 5.69% |
![]() Eaton Corporation Plc | Buy | $113.7B | 235.85% | 31.45 | 15.12% |
Insights on Idex Corporation
Revenue is up for the last 3 quarters, 788.9M → 807.2M (in $), with an average increase of 1.1% per quarter
Netprofit is up for the last 3 quarters, 108.6M → 141.3M (in $), with an average increase of 12.3% per quarter
In the last 1 year, Parker-hannifin Corporation has given 39.6% return, outperforming this stock by 50.3%
In the last 3 years, Parker-hannifin Corporation has given 97.1% return, outperforming this stock by 107.2%
Vanguard Group Inc
BlackRock Inc
T. Rowe Price Associates, Inc.
State Street Corporation
Morgan Stanley - Brokerage Accounts
Impax Asset Management Group PLC
In the quarter ending March,2024. Idex Corporation has declared dividend of $0.64
Read Moreidex (nyse: iex) is a company that has undoubtedly touched your life in some way. in fact, idex businesses make thousands of products that are mission-critical components in everyday activities. chances are the car you’re driving has a band-it® clamp holding your side airbag safely in place. if you were ever in a car accident, a hurst jaws of life® rescue tool may have saved your life. if you or a family member is battling cancer, your doctor may have tested your dna in a quest to find the best targeted medicine for you. it’s likely your dna test was run on equipment that contains components made by our growing idex health & science team.
Organization | Idex Corporation |
Employees | 8800 |
CEO | Mr. Eric D. Ashleman |
Industry | Producer Manufacturing |
Sirius Xm Holdings Inc.
$195.14
-0.83%
Cognizant Technology Solutions Corp.
$195.14
-0.83%
Molina Healthcare, Inc.
$195.14
-0.83%
Southwest Airlines Co.
$195.14
-0.83%
Simon Property Group Inc.
$195.14
-0.83%
Packaging Corporation Of America
$195.14
-0.83%
Renaissancere Holdings Ltd.
$195.14
-0.83%
Philip Morris International, Inc.
$195.14
-0.83%
Airbnb
$195.14
-0.83%